Delayed parasite elimination in human infections treated with clindamycin parallels ‘delayed death’ of Plasmodium falciparum in vitro-Reference-Cited by-同舟云学术

Delayed parasite elimination in human infections treated with clindamycin parallels ‘delayed death’ of Plasmodium falciparum in vitro

Published:2007-06 Issue:7 Volume:37 Page:777-785
ISSN:0020-7519
Container-title:International Journal for Parasitology
language:en
Short-container-title:International Journal for Parasitology

Author:

Burkhardt Dominik,Wiesner Jochen,Stoesser Nicole,Ramharter Michael,Uhlemann Anne-Catrin,Issifou Saadou,Jomaa Hassan,Krishna Sanjeev,Kremsner Peter G.,Borrmann Steffen

Publisher

Elsevier BV

Subject

Infectious Diseases,Parasitology

Reference33 articles.

1. Fosmidomycin-clindamycin for Plasmodium falciparum infections in african children;Borrmann;J. Infect. Dis.,2004

2. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria;Borrmann;J. Infect. Dis.,2004

3. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii;Camps;Mol. Microbiol.,2002

4. Intracellular pharmacodynamics of antibiotics;Carryn;Infect. Dis. Clin. North Am.,2003

5. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii;Fichera;Antimicrob. Agents Chemother.,1995

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Antimalarial Treatments: Focus on Artemisia annua Dry Leaf;Malaria - Recent Advances and New Perspectives;2023-04-05

2. Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya;Malaria Journal;2022-06-21

3. The delayed death-causing nature of Rosmarinus officinalis leaf extracts and their mixture within experimental chronic toxoplasmosis: Therapeutic and prophylactic implications;Acta Tropica;2021-09

4. Antiplasmodial activity of the natural product compounds alstonine and himbeline;International Journal for Parasitology: Drugs and Drug Resistance;2021-08

5. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials;ACS Infectious Diseases;2020-02-20